Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea

Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea

US Patent 8481583 · Granted Jul 9, 2013

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosing of incretin pathway drugs2025
Apixaban dosing2025
Methods and systems for providing personalised medicine to a patient2023
Antibacterial compounds2017
Antibacterial compounds2016
Antibacterial compounds2015
Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (ox2014
Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (ox2014
Compositions and methods for diagnosis and treatment of tumors2013
Compositions and methods for diagnosis and treatment of tumors2012
Methods for delivering biologically active molecules into cells2005
Substituted phenyl compounds with a substituent having a thienyl ring2000